BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia

Journal of Molecular and Cellular Cardiology

Volumn 68, Issue , 2014, Pages 89-97

  Helan, Martin ^a,c   Aravamudan, Bharathi ^a   Hartman, William R ^a,b   Thompson, Michael A ^a   Johnson, Bruce D ^a   Pabelick, Christina M ^a,b   Prakash, Y S ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

ENOS; Hypoxia inducible factor 1; INOS; Neurotrophin; Nitric oxide; Tropomyosin related kinase

Indexed keywords

ENOS; HYPOXIA INDUCIBLE FACTOR 1; INOS; NEUROTROPHIN; NITRIC OXIDE; TROPOMYOSIN RELATED KINASE;

ANOXIA; ARGINASE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL HYPOXIA; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN KINASES; PULMONARY ARTERY; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84894279068     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.01.006     Document Type: Article

References (45)

1. Frumkin L.R. The pharmacological treatment of pulmonary arterial hypertension. Pharmacol Rev 2012, 64:583-620.
2. Tajsic T., Morrell N.W. Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. Compr Physiol 2011, 1:295-317.
3. Sakao S., Tatsumi K., Voelkel N.F. Reversible or irreversible remodeling in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 2010, 43:629-634.
4. Morrell N.W., Adnot S., Archer S.L., Dupuis J., Jones P.L., MacLean M.R., et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54:S20-S31.
5. Humbert M., Gerry Coghlan J., Khanna D. Early detection and management of pulmonary arterial hypertension. Eur Respir Rev 2012, 21:306-312.
6. McGlothlin D. Classification of pulmonary hypertension. Heart Fail Clin 2012, 8:301-317.
7. McGoon M.D., Miller D.P. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev 2012, 21:8-18.
8. Fish J.E., Matouk C.C., Yeboah E., Bevan S.C., Khan M., Patil K., et al. Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase. J Biol Chem 2007, 282:15652-15666.
9. Murata T., Sato K., Hori M., Ozaki H., Karaki H. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J Biol Chem 2002, 277:44085-44092.
10. Fagan K.A., Morrissey B., Fouty B.W., Sato K., Harral J.W., Morris K.G., et al. Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension. Respir Res 2001, 2:306-313.
11. Fagan K.A., Tyler R.C., Sato K., Fouty B.W., Morris K.G., Huang P.L., et al. Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. Am J Physiol 1999, 277:L472-L478.
12. Hampl V., Herget J. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 2000, 80:1337-1372.
13. Beleslin-Cokic B.B., Cokic V.P., Wang L., Piknova B., Teng R., Schechter A.N., et al. Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells. Cytokine 2011, 54:129-135.
14. Barbacid M. Neurotrophic factors and their receptors. Curr Opin Cell Biol 1995, 7:148-155.
15. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev 2003, 4:299-309.
16. Chao M.V., Rajagopal R., Lee F.S. Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006, 110:167-173.
17. Aravamudan B., Thompson M., Pabelick C., Prakash Y.S. Brain-derived neurotrophic factor induces proliferation of human airway smooth muscle cells. J Cell Mol Med 2012, 16:812-823.
18. Meuchel L.W., Thompson M.A., Cassivi S.D., Pabelick C.M., Prakash Y.S. Neurotrophins induce nitric oxide generation in human pulmonary artery endothelial cells. Cardiovasc Res 2011, 91:668-676.
19. Prakash Y.S., Iyanoye A., Ay B., Mantilla C.B., Pabelick C.M. Neurotrophin effects on intracellular Ca2+ and force in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2006, 291:L447-L456.
20. Hoyle G.W. Neurotrophins and lung disease. Cytokine Growth Factor Rev 2003, 14:551-558.
21. Nassenstein C., Kerzel S., Braun A. Neurotrophins and neurotrophin receptors in allergic asthma. Prog Brain Res 2004, 146:347-367.
22. Ricci A., Greco S., Amenta F., Bronzetti E., Felici L., Rossodivita I., et al. Neurotrophins and neurotrophin receptors in human pulmonary arteries. J Vasc Res 2000, 37:355-363.
23. Prakash Y.S., Thompson M.A., Meuchel L., Pabelick C.M., Mantilla C.B., Zaidi S., et al. Neurotrophins in lung health and disease. Expert Rev Respir Med 2010, 4:395-411.
24. Kim H., Li Q., Hempstead B.L., Madri J.A. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J Biol Chem 2004, 279:33538-33546.
25. Wang H., Yuan G., Prabhakar N.R., Boswell M., Katz D.M. Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling. J Neurochem 2006, 96:694-705.
26. Wilkerson J.E.R., Mitchell G.S. Daily intermittent hypoxia augments spinal BDNF levels, ERK phosphorylation and respiratory long-term facilitation. Exp Neurol 2009, 217:116-123.
27. Okada S., Yokoyama M., Toko H., Tateno K., Moriya J., Shimizu I., et al. Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway. Arterioscler Thromb Vasc Biol 2012, 32:1902-1909.
28. Nakamura K., Martin K.C., Jackson J.K., Beppu K., Woo C.-W., Thiele C.J. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1α in neuroblastoma cells. Cancer Res 2006, 66:4249-4255.
29. Sciesielski L.K., Paliege A., Martinka P., Scholz H. Enhanced pulmonary expression of the TrkB neurotrophin receptor in hypoxic rats is associated with increased acetylcholine-induced airway contractility. Acta Physiol 2009, 197:253-264.
30. Rey S., Semenza G.L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 2010, 86:236-242.
31. Prabhakar N.R., Semenza G.L. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 2012, 92:967-1003.
32. Martens L.K., Kirschner K.M., Warnecke C., Scholz H. Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene. J Biol Chem 2007, 282:14379-14388.
33. Yu J., Taylor L., Wilson J., Comhair S., Erzurum S., Polgar P. Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pumonary arterial hypertension. J Cell Phyiol 2013, 228:322-329.
34. Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005, 26:115-123.
35. Jevtovic S., Karlovic D., Mihaljevic-Peles A., Seric V., Vrkic N., Jaksic N. Serum brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression. Psychiatr Danub 2011, 23:363-369.
36. Karczewska-Kupczewska M., Kowalska I., Nikolajuk A., Adamska A., Zielinska M., Kaminska N., et al. Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fat meal in young healthy male subjects. Diabetes Care 2012, 35:358-362.
37. Sathish V., Vanoosten S.K., Miller B.S., Aravamudan B., Thompson M.A., Pabelick C.M., et al. Brain-derived neurotrophic factor in cigarette smoke-induced airway hyperreactivity. Am J Respir Cell Mol Biol 2013, 48:431-438.
38. Hu R., Dai A., Tan S. Hypoxia-inducible factor 1 alpha upregulates the expression of inducible nitric oxide synthase gene in pulmonary arteries of hyposic rat. Chin Med J (Engl) 2002, 115:1833-1837.
39. Matrone C., Pignataro G., Molinaro P., Irace C., Scorziello A., Di Renzo G.F., et al. HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J Neurochem 2004, 90:368-378.
40. Ricci A., Felici L., Mariotta S., Mannino F., Schmid G., Terzano C., et al. Neurotrophin and neurotrophin receptor protein expression in the human lung. Am J Respir Cell Mol Biol 2004, 30:12-19.
41. Westbroek E.M., Pawlikowska L., Lawton M.T., McCulloch C.E., Young W.L., Kim H. Brain-derived neurotrophic factor Val66Met polymorphism predicts worse functional outcome after surgery in patients with unruptured brain arteriovenous malformation. Stroke 2012, 43:2255-2257.
42. Lazarovici P., Cohen G., Arien-Zakay H., Chen J., Zhang C., Chopp M., et al. Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models. J Mol Neurosci 2012, 48:526-540.
43. Mackin P., Gallagher P. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol 2005, 105:352.
44. Krotova K., Patel J.M., Block E.R., Zharikov S. Hypoxic upregulation of arginase II in human lung endothelial cells. Am J Physiol Cell Physiol 2010, 299:C1541-C1548.
45. Matsuda S., Fujita T., Kajiya M., Takeda K., Shiba H., Kawaguchi H., et al. Brain-derived neurotrophic factor induces migration of endothelial cells through a TrkB-ERK-integrin alphaVbeta3-FAK cascade. J Cell Physiol 2012, 227:2123-2129.